Research programme: G protein-coupled receptor targeted biologics - Genentech/Nxera Pharma
Alternative Names: GPCR-targeted antibodies - Genentech/Nxera PharmaLatest Information Update: 02 Apr 2024
At a glance
- Originator Sosei Heptares
- Developer Genentech; Nxera Pharma
- Class Antibodies
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified